Twist Bioscience is laying off 212 employees, effective July 3, according to California WARN notices — with 197 of those staffers in San Francisco.
The synthetic DNA manufacturer had announced a strategic restructuring plan in May that includes laying off 270 employees, or 25% of its workforce, starting in its fiscal third quarter.
Twist had $315,196,000 in cash and cash equivalents as of March 31, with debt of $929,396,000.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters